It is a chemicals private limited company based in Hubballi, Karnataka, India, established in 2019.
2019 | Hubballi, Karnataka, India | ActiveNeomaxx Pharmaceuticals Private Limited, a active private limited company, was established on 20 September 2019 in Hubballi, Karnataka, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230KA2019PTC128124. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.40 M.
Its leadership includes Drsuresh Yeshwanth Patil (Director), Narasimhan Raju (Director), Bramhavar Shamburao Ramesh (Director). Past directors included Prabhakar Shankaran. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shivalingamma Heerad Memorial Complex, 3 Floor 3 Cross, Hosur, Hubballi, Karnataka, 580021.
U24230KA2019PTC128124
128124
20 September 2019
₹1.00 M
₹0.40 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Neomaxx Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Drsuresh Yeshwanth Patil | Director | 20 Sep 2019 | Current |
| Narasimhan Raju | Director | 21 Mar 2020 | Current |
| Bramhavar Shamburao Ramesh | Director | 21 Mar 2020 | Current |
| Vishnu Prabhu | Director | 21 Mar 2020 | Current |
| Sharanabasappa Kamreddy | Director | 21 Mar 2020 | Current |
| Prashant Shivappa Holkunde | Director | 20 Sep 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Mar 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neomaxx Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Neomaxx Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Neomaxx Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Neomaxx Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neomaxx Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Neomaxx Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Neomaxx Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
Basalingappa Channabasappa Navadgi was appointed as a Director was appointed as a Director on 30 Jan 2022 & has been associated with this company since 3 years 11 months . was recorded as a recent event.
The activity Narasimhan Raju was appointed as a Director was appointed as a Director on 21 Mar 2020 & has been associated with this company since 5 years 9 months . was completed.
The activity Bramhavar Shamburao Ramesh was appointed as a Director was appointed as a Director on 21 Mar 2020 & has been associated with this company since 5 years 9 months . was completed.
Vishnu Prabhu was appointed as a Director was appointed as a Director on 21 Mar 2020 & has been associated with this company since 5 years 9 months . was recorded as a recent event.
The CIN of Neomaxx Pharmaceuticals Private Limited is U24230KA2019PTC128124.
Neomaxx Pharmaceuticals Private Limited is headquartered at Shivalingamma Heerad Memorial Complex, 3 Floor 3 Cross, Hosur, Hubballi, Karnataka, 580021.
Neomaxx Pharmaceuticals Private Limited was incorporated on 20 September 2019.
The current directors of Neomaxx Pharmaceuticals Private Limited are
The primary industry of Neomaxx Pharmaceuticals Private Limited is Chemicals.
Neomaxx Pharmaceuticals Private Limited is unlisted.
The authorized capital of Neomaxx Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.40 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX